Pear Therapeutics was a leader in developing and commercializing prescription digital therapeutics (PDTs), which are FDA-cleared software applications designed to treat serious diseases. Their approach integrated clinically validated software with pharmaceuticals to improve patient outcomes, provide clinician tools, and offer cost-effective solutions for payers. The company aimed to redefine care through the widespread use of these software-based therapeutics.